Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsPharma and it

    Pharma And It

    Jump to

    • Trump's tariff to hurt these sectors most-exposed to US; may shave off up to 50bps of growth

      Market experts said the IT sector, along with gems and jewellery sector could be staring at a negative impact, given the heavy reliance on US demand. EMS may not get as badly affected owing to concessions for manufacturing in India. Even though Trump’s tariff threat was getting digested by the market in phases, the near 50 percent tariff rate is no good for the short term, analysts agreed.

    • Expect Nifty to touch 6200 by year end: Anu Jain

      Bank Nifty is still below the 200-day moving average, says Jain. Though private banks such as ICICI Bank, HDFC Bank, Axis Bank, Yes Bank, IndusInd Bank are showing some signs of recovery

    • Market valuations reasonable; find out 3 sectors BoA-ML is bullish on

      In an exclusive interview with CNBC-TV18, Jyotivardhan Jaipuria head-research with Bank of America Merrill Lynch says that the Indian market valuations currently reasonable. He is bullish on “the sectors of banking, pharma and IT.” He is however not bullish on the infrastructure space.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347